evoluzione del fenomeno della droga in europa - EMCDDA - Europa

Riferimenti bibliografici
ACPO Drugs Committee (2002), A review of drugs policy and
proposals for the future, The Association of Chief Police Officers,
Londra.
Bossong, M.G., Van Dijk, J.P. e Niesink, R.J.M. (2005),
«Methylone and mCPP, two new drugs of abuse?», Addiction
biology 10(4), pagg. 321-323.
Burrell, K., Jones, L., Sumnall, H. e altri (2005), Tiered approach
to drug prevention and treatment among young people, National
Collaborating Centre for Drug Prevention, Liverpool.
Chen, C.-Y., O’Brien, M.S. e Anthony, J.C. (2005), «Who
becomes cannabis dependent soon after onset of use?
Epidemiological evidence from the United States: 2000-2001»,
Drug and alcohol dependence 79, pagg. 11-22.
Chivite-Matthews, N., Richardson, A., O’Shea, J. e altri (2005),
Drug misuse declared: findings from the 2003/04 British Crime
Survey, Home Office statistical bulletin 04/05, Home Office, Londra
(http://www.homeoffice.gov.uk/rds/pdfs05/hosb0405.pdf).
Commission on Narcotic Drugs (CND) (2005), World drug
situation with regard to drug trafficking: Report of the Secretariat,
commissione stupefacenti, Consiglio economico e sociale delle
Nazioni Unite, Vienna.
CND (2006), World drug situation with regard to drug trafficking:
Report of the Secretariat, commissione stupefacenti, Consiglio
economico e sociale delle Nazioni Unite, Vienna.
EuroHIV (2005), HIV/AIDS surveillance in Europe: End-year report
2004, Institute de veille sanitaire: Saint-Maurice, n. 71.
Europol (2006), «Drugs 2006» (comunicazione all’OEDT del
16 gennaio 2006, archivio n. 158448), Europol, L’Aja.
Farrell, M., Gowing, L., Marsden, J. e altri (2005), «Effectiveness
of drug dependence treatment in HIV prevention», International
journal of drug policy 16S, pagg. S67-75.
Haasen, C., Prinzleve, M., Gossop, M. e altri (2005),
«Relationship between cocaine use and mental health problems in
a sample of European cocaine powder and crack users», World
psychiatry, 4(3), pagg. 173-176.
Hibell, B., Andersson, B., Bjarnasson, T. e altri (2004), The
ESPAD report 2003: alcohol and other drug use among students
in 35 European countries, Consiglio svedese di informazione su
alcool e altre droghe (CAN) e gruppo Pompidou del Consiglio
d’Europa.
Higgins, S.T., Sigmon, S.C., Wong, C.J. e altri (2003),
«Community reinforcement therapy for cocaine-dependent
outpatients», Archives of general psychiatry 60, pagg.
1043-1052.
International Narcotics Control Board (INCB) (2006a), Report of
the International Narcotics Control Board for 2005, Comitato per
il controllo nazionale dei narcotici delle Nazioni Unite, New York.
INCB (2006b), Precursors and chemicals frequently used in the
illicit manufacture of narcotic drugs and psychotropic substances,
Comitato per il controllo nazionale dei narcotici delle Nazioni
Unite, New York.
Kandel, D. e Davis, M. (1992), «Progression to regular marijuana
involvement: Phenomenology and risk factors for near daily
use», in: Glantz, M. e Pickens, R. (eds), Vulnerability to Drug
Abuse pagg. 211-253, American Psychological Association,
Washington.
Kumpfer, K.L., Molgaard, C.F.R. e Spoth, R. (1996), «The
Strengthening Families Program for prevention of delinquency and
drug use in special populations», in: Peters, R. e McMahon, R. J.
(eds) Childhood disorders, substance abuse, and delinquency:
prevention and early intervention approaches, Sage Publications,
Newbury Park, CA.
MacDonald, Z., Tinsley, L., Collingwood, J. e altri (2005),
Measuring the harm from illegal drugs using the drug harm index,
Home Office Online Report 24/05, Home Office, Londra
(http://www.homeoffice.gov.uk/rds/pdfs05/rdsolr2405.pdf).
Naber, D. e Haasen, C. (2006), Das bundesdeutsche
Modellprojekt zur heroingestützten Behandlung
Opiatabhängiger — eine multizentrische, randomisierte,
kontrollierte Therapiestudie, Hamburg: Zentrum für
interdisziplinäre Suchtforschung der Universität Hamburg
(http://www.heroinstudie.de/ZIS_H-Bericht_P1_DLR.pdf).
OEDT (2002a), Prosecution of drug users in Europe — varying
pathways to similar objectives, Osservatorio europeo delle droghe
e delle tossicodipendenze, Lisbona.
OEDT (2002b), «Mortality of drug users in the EU: coordination
of implementation of new cohort studies, follow-up and analysis of
existing cohorts and development of new methods and outputs»,
Project CT.00.EP.13, Osservatorio europeo delle droghe e delle
tossicodipendenze, Lisbona.
OEDT (2004a), 2004 Annual report on the drugs problem in the
European Union and Norway, Osservatorio europeo delle droghe
e delle tossicodipendenze, Lisbona.
OEDT (2004b), An overview of cannabis potency in Europe,
Insights no. 6, Osservatorio europeo delle droghe e delle
tossicodipendenze, Lisbona.
OEDT (2004c), European report on drug consumption rooms,
Osservatorio europeo delle droghe e delle tossicodipendenze,
Lisbona.
95